<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04609228</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-TRA-2020-36</org_study_id>
    <nct_id>NCT04609228</nct_id>
  </id_info>
  <brief_title>Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors</brief_title>
  <official_title>Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors: a Retrospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to analyze mortality after cardiac surgery in&#xD;
      blood-transfusion non-acceptors (BTNA), and the secondary one to perform an adjusted&#xD;
      comparison with a blood-transfusion acceptors (BTA) matched cohort.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2020</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change on Hemoglobin values from preoperative to end-of-surgery levels</measure>
    <time_frame>End-of-surgery</time_frame>
    <description>Changes on Hemoglobin values in percentage from preoperative level to the end of the surgery level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of operative mortality</measure>
    <time_frame>At discharge or within the first 30 postoperative days</time_frame>
    <description>Any death occurring i) within the first 30 postoperative days in or out of the hospital, and ii) after 30 days during the same hospitalization subsequent to the operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative fluid balance</measure>
    <time_frame>End of surgery</time_frame>
    <description>Resting the fluid outputs to inputs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin at discharge</measure>
    <time_frame>At discharge, an average of 10 days</time_frame>
    <description>Hemoglobin level at discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of postoperative morbidity</measure>
    <time_frame>At discharge, an average of 10 days</time_frame>
    <description>Postoperative complications: hemodynamic, respiratory, renal, neurological, infective complications</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1911</enrollment>
  <condition>Thoracic Surgery</condition>
  <condition>Blood Transfusion; Hemoglobinemia</condition>
  <condition>Cardiac Disease</condition>
  <arm_group>
    <arm_group_label>Blood-transfusion non-acceptors</arm_group_label>
    <description>Blood-transfusion non-acceptors</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blood-transfusion acceptors</arm_group_label>
    <description>Blood-transfusion acceptors</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-acceptance of blood-transfusions</intervention_name>
    <description>Patients who do not accept blood products transfusions</description>
    <arm_group_label>Blood-transfusion non-acceptors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acceptance of blood-transfusions</intervention_name>
    <description>Patients who accept blood products transfusions</description>
    <arm_group_label>Blood-transfusion acceptors</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing heart surgery in our hospital from 2009 to June 2020. Patients were&#xD;
        categorized in blood-transfusion non-acceptors (exposed cohort) and blood-transfusion&#xD;
        acceptors (control cohort)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing heart surgery in our hospital from 2009 to June 2020&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Preoperative hemoglobin lower than 120g/L&#xD;
&#xD;
          -  EuroSCORE-II higher than 20%&#xD;
&#xD;
          -  Heart transplant&#xD;
&#xD;
          -  Assist device implantation&#xD;
&#xD;
          -  Surgery of acute myocardial infarction-derived complications&#xD;
&#xD;
          -  Other emergent cardiac surgeries (acute aortic dissection, heart injuries).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena Roselló-Díez, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiac surgeon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elena Roselló-Díez, MD, PhD</last_name>
    <phone>+34 935565957</phone>
    <email>erosello@santpau.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fundació de Gestió Sanitària de l'Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Roselló-Díez, MD, PhD</last_name>
      <phone>+34 935565957</phone>
      <email>erosello@santpau.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2020</study_first_posted>
  <last_update_submitted>October 30, 2020</last_update_submitted>
  <last_update_submitted_qc>October 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Undecided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

